Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
US Chia is an agricultural technology and animal health company that produces and markets high-quality chia seeds specifically for the equine and human nutrition markets. Founded as a spin-out from the University of Kentucky, the company focuses on providing a domestic, traceable source of Omega-3 fatty acids, fiber, and antioxidants. Their flagship products are designed to support equine wellness, targeting issues such as sand colic, coat quality, and joint inflammation. By maintaining a US-based supply chain, US Chia ensures high purity and nutritional standards for its supplement line. The company's research-driven approach distinguishes it within the nutraceutical industry, emphasizing the health benefits of chia as a whole-food supplement.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on US Chia.